Skip to main content
Log in

Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative

  • 2019 SSAT Plenary Presentation
  • Published:
Journal of Gastrointestinal Surgery

Abstract

Background

Appendiceal adenocarcinoma with signet ring cells (SCA) is associated with worse overall survival (OS), and it is unclear whether cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) should be pursued in this patient population. We assessed the prognostic implications of signet ring cells in patients with appendiceal adenocarcinoma and peritoneal carcinomatosis undergoing CRS-HIPEC.

Methods

The US HIPEC Collaborative, a 12-center, multi-institutional database of patients undergoing CRS-HIPEC, was reviewed for patients with SCA. Univariate and multivariate analyses were performed.

Results

Of 514 patients undergoing CRS-HIPEC for appendiceal adenocarcinoma, 125 (24%) had SCA. The SCA and non-SCA groups had similar baseline characteristics. SCA had worse OS compared with non-SCA (32.0 vs 91.4 months, p < 0.001). In univariate analysis for only SCA cases, there was worse OS in patients with poorly differentiated tumors, positive lymph nodes, LVI, PCI > 20, or incomplete cytoreduction (CC-2/3). However, multivariate analysis showed only positive lymph nodes (HR 1.14 [95% CI 1.00–1.31], p = 0.04), poor differentiation (5.60 [1.29–24.39], p = 0.02), and incomplete cytoreduction (4.90 [1.11–12.70], p = 0.03) were independently associated with decreased OS for SCA.

Conclusion

While signet cells are a negative prognostic feature, they should not be a contraindication to CRS-HIPEC in patients with well-moderately differentiated tumors with negative lymph nodes, where complete cytoreduction can be achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJ. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012;23:652-658.

    Article  CAS  Google Scholar 

  2. Ihemelandu C, Sugarbaker PH. Clinicopathologic and prognostic features in patients with peritoneal metastasis from mucinous adenocarcinoma, adenocarcinoma with signet ring cells, and adenocarcinoid of the appendix treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:1474-1480.

    Article  Google Scholar 

  3. Smeenk RM, van Velthuysen MLF, Verwaal VJ, Zoetmulder FAN. Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol. 2008;34:196-201.

    Article  CAS  Google Scholar 

  4. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69-76.

    Article  Google Scholar 

  5. Elias D, Glehen O, Pocard M, Quenet F, Goéré D, Arvieux C, Rat P, Gilly F, the Association Francaise de Chirurgie. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg. 2010;251:896-901.

    Article  Google Scholar 

  6. Rajeev R, Klooster B, Turaga KK. Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion. J Gastrointest Oncol. 2016;7(1):122-128.

    PubMed  PubMed Central  Google Scholar 

  7. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85-91.

    Article  CAS  Google Scholar 

  8. El Halabi H, Gushchin V, Francis J, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19:110-114.

    Article  Google Scholar 

  9. Carr NJ, Cecil TD, Mohammed F, Sobin LH, Sugarbaker PH, Gonzalez-Moreno S, Taflampas P, Chapman S, Moran BJ. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: The results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol. 2016;40(1):14-26.

    Article  Google Scholar 

  10. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240(2):278-285.

    Article  Google Scholar 

  11. Grotz TE, Overman MJ, Eng C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: survival outcomes and patient selection. Ann Surg Oncol. 2017;24:2646-2654.

    Article  Google Scholar 

  12. Turaga KK, Pappas SG, Gamblin TC. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379-1385.

    Article  Google Scholar 

  13. Kwakman R, Schrama AM, van Olmen JP, Otten RH, de Lange-de Klerk ES, de Cuba EM, Kazemier G. Clinicopathologic parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg. 2016;263(6):1102-1111.

    Article  Google Scholar 

  14. Solomon D, DeNicola N, Feingold D, Liu PH, Aycart S, Golas BJ, Sarpel U, Labow DM, Magge DR. Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival. J Surg Oncol. 2019;1-8.

  15. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FAN. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2004;91:739-746.

    Article  CAS  Google Scholar 

  16. Chua TC, Pelz JOW, Kerscher A, Morris DL, Esquivel J. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma. Ann Surg Oncol. 2009;16:2765-2770.

    Article  Google Scholar 

  17. Chua TC, Koh J, Yan TD, Liauw W, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. J Surg Oncol. 2009;100:139-143.

    Article  Google Scholar 

  18. Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250:878887.

    Article  Google Scholar 

  19. Van Oudheusden TR, Braam HJ, Nienhuijs SW, Wiezer MJ, van Ramshorst, Luyer P, de Hingh IH. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol. 2015;111:237-242.

    Article  Google Scholar 

  20. Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014;45(8):1597-1604.

    Article  CAS  Google Scholar 

  21. Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol. 2017;9(9):354-362.

    Article  Google Scholar 

  22. Omohow C, Nieroda CA, Studeman KD, et al. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009;209(3):308-312.

    Article  Google Scholar 

  23. Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, Ramalingam L, Kandiah C, Chouliaras K, Shen P, Levine EA. PCI is not predictive of survival after complete CRS/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol. 2018; 25(3):674-678.

    Article  Google Scholar 

  24. Milvanov V, Sardi A, Ledakis P, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). Eur J Surg Oncol. 2015:707-712.

Download references

Author information

Authors and Affiliations

Authors

Contributions

Nick C Levinsky MD: Data collection, statistical analysis, manuscript preparation

Mackenzie C Morris MD: Data collection, statistical analysis, manuscript preparation

Koffi Wima MS: Statistical analysis

Jeffrey J Sussman MD: Provision of patients, critical review of the manuscript

Syed A Ahmad MD: Provision of patients, critical review of the manuscript

Jordan M Cloyd MD: Provision of patients, critical review of the manuscript

Charles Kimbrough MD: Provision of patients, critical review of the manuscript

Keith Fournier MD: Provision of patients, critical review of the manuscript

Andrew Lee MD: Provision of patients, critical review of the manuscript

Sean Dineen MD: Provision of patients, critical review of the manuscript

Sophie Dessureault MD PhD: Provision of patients, critical review of the manuscript

Jula Veerapong MD: Provision of patients, critical review of the manuscript

Joel M Baumgartner MD MAS: Provision of patients, critical review of the manuscript

Callisia Clarke MD: Provision of patients, critical review of the manuscript

Mohammad Y Zaidi MD MS: Provision of patients, critical review of the manuscript

Charles A Staley MD: Provision of patients, critical review of the manuscript

Shishir K Maithel MD: Provision of patients, critical review of the manuscript

Jennifer Leiting MD: Provision of patients, critical review of the manuscript

Travis Grotz MD: Provision of patients, critical review of the manuscript

Laura Lambert MD: Provision of patients, critical review of the manuscript

Ryan J Hendrix MD: Provision of patients, critical review of the manuscript

Sean Ronnekleiv-Kelly MD: Provision of patients, critical review of the manuscript

Courtney Pokrzywa MD: Provision of patients, critical review of the manuscript

Mustafa Raoof MD: Provision of patients, critical review of the manuscript

Oliver S Eng MD: Provision of patients, critical review of the manuscript

Fabian M Johnston MD MHS: Provision of patients, critical review of the manuscript

Jonathan Greer MD: Provision of patients, critical review of the manuscript

Sameer H Patel MD: Study design, provision of patients, statistical analysis, manuscript preparation

Corresponding author

Correspondence to Sameer H. Patel.

Ethics declarations

Conflict of Interest Statements

The authors declare that they have no conflict of interest.

Additional information

Presentation

The Presidential Plenary Session at 60th Annual Meeting of The Society for Surgery of the Alimentary Tract, May 19, 2019, San Diego, California.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levinsky, N.C., Morris, M.C., Wima, K. et al. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg 24, 155–164 (2020). https://doi.org/10.1007/s11605-019-04336-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-019-04336-4

Keywords

Navigation